1 Market Overview

1.1 Product Overview and Scope of Covid-19 Treatment

1.2 Classification of Covid-19 Treatment by Type

1.2.1 Overview: Global Covid-19 Treatment Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Covid-19 Treatment Revenue Market Share by Type in 2020

1.2.3 Respiratory Support

1.2.4 Circulatory Support.

1.2.5 Convalescent Plasma Therapy

1.2.6 Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin)

1.2.7 Antimicrobial Therapy

1.2.8 Renal Failure and Renal Replacement Therapy

1.2.9 Lung Replacement Therapy

1.2.10 Immunotherapy

1.2.11 Other therapeutic measures

1.3 Global Covid-19 Treatment Market by Application

1.3.1 Overview: Global Covid-19 Treatment Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Children

1.3.3 Adult

1.3.4 Special Groups

1.4 Global Covid-19 Treatment Market Size & Forecast

1.5 Global Covid-19 Treatment Market Size and Forecast by Region

1.5.1 Global Covid-19 Treatment Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Covid-19 Treatment Market Size by Region, (2016-2021)

1.5.3 North America Covid-19 Treatment Market Size and Prospect (2016-2026)

1.5.4 Europe Covid-19 Treatment Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Covid-19 Treatment Market Size and Prospect (2016-2026)

1.5.6 South America Covid-19 Treatment Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Covid-19 Treatment Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Covid-19 Treatment Market Drivers

1.6.2 Covid-19 Treatment Market Restraints

1.6.3 Covid-19 Treatment Trends Analysis

2 Company Profiles

2.1 Applied DNA Sciences, Inc

2.1.1 Applied DNA Sciences, Inc Details

2.1.2 Applied DNA Sciences, Inc Major Business

2.1.3 Applied DNA Sciences, Inc Covid-19 Treatment Product and Solutions

2.1.4 Applied DNA Sciences, Inc Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Applied DNA Sciences, Inc Recent Developments and Future Plans

2.2 Codagenix

2.2.1 Codagenix Details

2.2.2 Codagenix Major Business

2.2.3 Codagenix Covid-19 Treatment Product and Solutions

2.2.4 Codagenix Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Codagenix Recent Developments and Future Plans

2.3 GeoVax Labs, Inc.

2.3.1 GeoVax Labs, Inc. Details

2.3.2 GeoVax Labs, Inc. Major Business

2.3.3 GeoVax Labs, Inc. Covid-19 Treatment Product and Solutions

2.3.4 GeoVax Labs, Inc. Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 GeoVax Labs, Inc. Recent Developments and Future Plans

2.4 Takis Biotech

2.4.1 Takis Biotech Details

2.4.2 Takis Biotech Major Business

2.4.3 Takis Biotech Covid-19 Treatment Product and Solutions

2.4.4 Takis Biotech Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Takis Biotech Recent Developments and Future Plans

2.5 Evvivax

2.5.1 Evvivax Details

2.5.2 Evvivax Major Business

2.5.3 Evvivax Covid-19 Treatment Product and Solutions

2.5.4 Evvivax Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Evvivax Recent Developments and Future Plans

2.6 Zydus Cadila

2.6.1 Zydus Cadila Details

2.6.2 Zydus Cadila Major Business

2.6.3 Zydus Cadila Covid-19 Treatment Product and Solutions

2.6.4 Zydus Cadila Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Zydus Cadila Recent Developments and Future Plans

2.7 MIGAL Galilee Research Institute

2.7.1 MIGAL Galilee Research Institute Details

2.7.2 MIGAL Galilee Research Institute Major Business

2.7.3 MIGAL Galilee Research Institute Covid-19 Treatment Product and Solutions

2.7.4 MIGAL Galilee Research Institute Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 MIGAL Galilee Research Institute Recent Developments and Future Plans

2.8 Generex Biotechnology Corporation

2.8.1 Generex Biotechnology Corporation Details

2.8.2 Generex Biotechnology Corporation Major Business

2.8.3 Generex Biotechnology Corporation Covid-19 Treatment Product and Solutions

2.8.4 Generex Biotechnology Corporation Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Generex Biotechnology Corporation Recent Developments and Future Plans

2.9 Moderna Therapeutics

2.9.1 Moderna Therapeutics Details

2.9.2 Moderna Therapeutics Major Business

2.9.3 Moderna Therapeutics Covid-19 Treatment Product and Solutions

2.9.4 Moderna Therapeutics Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Moderna Therapeutics Recent Developments and Future Plans

2.10 Novavax

2.10.1 Novavax Details

2.10.2 Novavax Major Business

2.10.3 Novavax Covid-19 Treatment Product and Solutions

2.10.4 Novavax Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Novavax Recent Developments and Future Plans

2.11 Bravovax

2.11.1 Bravovax Details

2.11.2 Bravovax Major Business

2.11.3 Bravovax Covid-19 Treatment Product and Solutions

2.11.4 Bravovax Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Bravovax Recent Developments and Future Plans

2.12 Ascletis Pharma

2.12.1 Ascletis Pharma Details

2.12.2 Ascletis Pharma Major Business

2.12.3 Ascletis Pharma Covid-19 Treatment Product and Solutions

2.12.4 Ascletis Pharma Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Ascletis Pharma Recent Developments and Future Plans

2.13 Janssen Pharmaceuticals

2.13.1 Janssen Pharmaceuticals Details

2.13.2 Janssen Pharmaceuticals Major Business

2.13.3 Janssen Pharmaceuticals Covid-19 Treatment Product and Solutions

2.13.4 Janssen Pharmaceuticals Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Janssen Pharmaceuticals Recent Developments and Future Plans

2.14 Altimmune

2.14.1 Altimmune Details

2.14.2 Altimmune Major Business

2.14.3 Altimmune Covid-19 Treatment Product and Solutions

2.14.4 Altimmune Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Altimmune Recent Developments and Future Plans

2.15 Greffex Inc.

2.15.1 Greffex Inc. Details

2.15.2 Greffex Inc. Major Business

2.15.3 Greffex Inc. Covid-19 Treatment Product and Solutions

2.15.4 Greffex Inc. Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Greffex Inc. Recent Developments and Future Plans

2.16 CanSino Biologics, Inc.

2.16.1 CanSino Biologics, Inc. Details

2.16.2 CanSino Biologics, Inc. Major Business

2.16.3 CanSino Biologics, Inc. Covid-19 Treatment Product and Solutions

2.16.4 CanSino Biologics, Inc. Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 CanSino Biologics, Inc. Recent Developments and Future Plans

2.17 ExpreS2ion Biotechnologies ApS

2.17.1 ExpreS2ion Biotechnologies ApS Details

2.17.2 ExpreS2ion Biotechnologies ApS Major Business

2.17.3 ExpreS2ion Biotechnologies ApS Covid-19 Treatment Product and Solutions

2.17.4 ExpreS2ion Biotechnologies ApS Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 ExpreS2ion Biotechnologies ApS Recent Developments and Future Plans

2.18 Clover Biopharmaceuticals

2.18.1 Clover Biopharmaceuticals Details

2.18.2 Clover Biopharmaceuticals Major Business

2.18.3 Clover Biopharmaceuticals Covid-19 Treatment Product and Solutions

2.18.4 Clover Biopharmaceuticals Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Clover Biopharmaceuticals Recent Developments and Future Plans

2.19 Vaxil Bio Ltd.

2.19.1 Vaxil Bio Ltd. Details

2.19.2 Vaxil Bio Ltd. Major Business

2.19.3 Vaxil Bio Ltd. Covid-19 Treatment Product and Solutions

2.19.4 Vaxil Bio Ltd. Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Vaxil Bio Ltd. Recent Developments and Future Plans

2.20 iBio Pharma Inc

2.20.1 iBio Pharma Inc Details

2.20.2 iBio Pharma Inc Major Business

2.20.3 iBio Pharma Inc Covid-19 Treatment Product and Solutions

2.20.4 iBio Pharma Inc Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 iBio Pharma Inc Recent Developments and Future Plans

2.21 Tonix Pharmaceuticals

2.21.1 Tonix Pharmaceuticals Details

2.21.2 Tonix Pharmaceuticals Major Business

2.21.3 Tonix Pharmaceuticals Covid-19 Treatment Product and Solutions

2.21.4 Tonix Pharmaceuticals Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Tonix Pharmaceuticals Recent Developments and Future Plans

2.22 Curevac

2.22.1 Curevac Details

2.22.2 Curevac Major Business

2.22.3 Curevac Covid-19 Treatment Product and Solutions

2.22.4 Curevac Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Curevac Recent Developments and Future Plans

2.23 ImmunoPrecise

2.23.1 ImmunoPrecise Details

2.23.2 ImmunoPrecise Major Business

2.23.3 ImmunoPrecise Covid-19 Treatment Product and Solutions

2.23.4 ImmunoPrecise Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 ImmunoPrecise Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Covid-19 Treatment Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Covid-19 Treatment Players Market Share

3.2.2 Top 10 Covid-19 Treatment Players Market Share

3.2.3 Market Competition Trend

3.3 Covid-19 Treatment Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Covid-19 Treatment Revenue and Market Share by Type (2016-2021)

4.2 Global Covid-19 Treatment Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Covid-19 Treatment Revenue Market Share by Application (2016-2021)

5.2 Covid-19 Treatment Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Covid-19 Treatment Revenue by Type (2016-2026)

6.2 North America Covid-19 Treatment Revenue by Application (2016-2026)

6.3 North America Covid-19 Treatment Market Size by Country

6.3.1 North America Covid-19 Treatment Revenue by Country (2016-2026)

6.3.2 United States Covid-19 Treatment Market Size and Forecast (2016-2026)

6.3.3 Canada Covid-19 Treatment Market Size and Forecast (2016-2026)

6.3.4 Mexico Covid-19 Treatment Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Covid-19 Treatment Revenue by Type (2016-2026)

7.2 Europe Covid-19 Treatment Revenue by Application (2016-2026)

7.3 Europe Covid-19 Treatment Market Size by Country

7.3.1 Europe Covid-19 Treatment Revenue by Country (2016-2026)

7.3.2 Germany Covid-19 Treatment Market Size and Forecast (2016-2026)

7.3.3 France Covid-19 Treatment Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Covid-19 Treatment Market Size and Forecast (2016-2026)

7.3.5 Russia Covid-19 Treatment Market Size and Forecast (2016-2026)

7.3.6 Italy Covid-19 Treatment Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Covid-19 Treatment Revenue by Type (2016-2026)

8.2 Asia-Pacific Covid-19 Treatment Revenue by Application (2016-2026)

8.3 Asia-Pacific Covid-19 Treatment Market Size by Region

8.3.1 Asia-Pacific Covid-19 Treatment Revenue by Region (2016-2026)

8.3.2 China Covid-19 Treatment Market Size and Forecast (2016-2026)

8.3.3 Japan Covid-19 Treatment Market Size and Forecast (2016-2026)

8.3.4 South Korea Covid-19 Treatment Market Size and Forecast (2016-2026)

8.3.5 India Covid-19 Treatment Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Covid-19 Treatment Market Size and Forecast (2016-2026)

8.3.7 Australia Covid-19 Treatment Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Covid-19 Treatment Revenue by Type (2016-2026)

9.2 South America Covid-19 Treatment Revenue by Application (2016-2026)

9.3 South America Covid-19 Treatment Market Size by Country

9.3.1 South America Covid-19 Treatment Revenue by Country (2016-2026)

9.3.2 Brazil Covid-19 Treatment Market Size and Forecast (2016-2026)

9.3.3 Argentina Covid-19 Treatment Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Covid-19 Treatment Revenue by Type (2016-2026)

10.2 Middle East & Africa Covid-19 Treatment Revenue by Application (2016-2026)

10.3 Middle East & Africa Covid-19 Treatment Market Size by Country

10.3.1 Middle East & Africa Covid-19 Treatment Revenue by Country (2016-2026)

10.3.2 Turkey Covid-19 Treatment Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Covid-19 Treatment Market Size and Forecast (2016-2026)

10.3.4 UAE Covid-19 Treatment Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Covid-19 Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Covid-19 Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Covid-19 Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Covid-19 Treatment Revenue (USD Million) by Region (2016-2021)

Table 5. Global Covid-19 Treatment Revenue Market Share by Region (2021-2026)

Table 6. Applied DNA Sciences, Inc Corporate Information, Head Office, and Major Competitors

Table 7. Applied DNA Sciences, Inc Major Business

Table 8. Applied DNA Sciences, Inc Covid-19 Treatment Product and Solutions

Table 9. Applied DNA Sciences, Inc Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Codagenix Corporate Information, Head Office, and Major Competitors

Table 11. Codagenix Major Business

Table 12. Codagenix Covid-19 Treatment Product and Solutions

Table 13. Codagenix Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. GeoVax Labs, Inc. Corporate Information, Head Office, and Major Competitors

Table 15. GeoVax Labs, Inc. Major Business

Table 16. GeoVax Labs, Inc. Covid-19 Treatment Product and Solutions

Table 17. GeoVax Labs, Inc. Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Takis Biotech Corporate Information, Head Office, and Major Competitors

Table 19. Takis Biotech Major Business

Table 20. Takis Biotech Covid-19 Treatment Product and Solutions

Table 21. Takis Biotech Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Evvivax Corporate Information, Head Office, and Major Competitors

Table 23. Evvivax Major Business

Table 24. Evvivax Covid-19 Treatment Product and Solutions

Table 25. Evvivax Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Zydus Cadila Corporate Information, Head Office, and Major Competitors

Table 27. Zydus Cadila Major Business

Table 28. Zydus Cadila Covid-19 Treatment Product and Solutions

Table 29. Zydus Cadila Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. MIGAL Galilee Research Institute Corporate Information, Head Office, and Major Competitors

Table 31. MIGAL Galilee Research Institute Major Business

Table 32. MIGAL Galilee Research Institute Covid-19 Treatment Product and Solutions

Table 33. MIGAL Galilee Research Institute Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Generex Biotechnology Corporation Corporate Information, Head Office, and Major Competitors

Table 35. Generex Biotechnology Corporation Major Business

Table 36. Generex Biotechnology Corporation Covid-19 Treatment Product and Solutions

Table 37. Generex Biotechnology Corporation Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Moderna Therapeutics Corporate Information, Head Office, and Major Competitors

Table 39. Moderna Therapeutics Major Business

Table 40. Moderna Therapeutics Covid-19 Treatment Product and Solutions

Table 41. Moderna Therapeutics Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Novavax Corporate Information, Head Office, and Major Competitors

Table 43. Novavax Major Business

Table 44. Novavax Covid-19 Treatment Product and Solutions

Table 45. Novavax Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Bravovax Corporate Information, Head Office, and Major Competitors

Table 47. Bravovax Major Business

Table 48. Bravovax Covid-19 Treatment Product and Solutions

Table 49. Bravovax Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Ascletis Pharma Corporate Information, Head Office, and Major Competitors

Table 51. Ascletis Pharma Major Business

Table 52. Ascletis Pharma Covid-19 Treatment Product and Solutions

Table 53. Ascletis Pharma Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Janssen Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 55. Janssen Pharmaceuticals Major Business

Table 56. Janssen Pharmaceuticals Covid-19 Treatment Product and Solutions

Table 57. Janssen Pharmaceuticals Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Altimmune Corporate Information, Head Office, and Major Competitors

Table 59. Altimmune Major Business

Table 60. Altimmune Covid-19 Treatment Product and Solutions

Table 61. Altimmune Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Greffex Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Greffex Inc. Major Business

Table 64. Greffex Inc. Covid-19 Treatment Product and Solutions

Table 65. Greffex Inc. Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. CanSino Biologics, Inc. Corporate Information, Head Office, and Major Competitors

Table 67. CanSino Biologics, Inc. Major Business

Table 68. CanSino Biologics, Inc. Covid-19 Treatment Product and Solutions

Table 69. CanSino Biologics, Inc. Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. ExpreS2ion Biotechnologies ApS Corporate Information, Head Office, and Major Competitors

Table 71. ExpreS2ion Biotechnologies ApS Major Business

Table 72. ExpreS2ion Biotechnologies ApS Covid-19 Treatment Product and Solutions

Table 73. ExpreS2ion Biotechnologies ApS Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Clover Biopharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 75. Clover Biopharmaceuticals Major Business

Table 76. Clover Biopharmaceuticals Covid-19 Treatment Product and Solutions

Table 77. Clover Biopharmaceuticals Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Vaxil Bio Ltd. Corporate Information, Head Office, and Major Competitors

Table 79. Vaxil Bio Ltd. Major Business

Table 80. Vaxil Bio Ltd. Covid-19 Treatment Product and Solutions

Table 81. Vaxil Bio Ltd. Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. iBio Pharma Inc Corporate Information, Head Office, and Major Competitors

Table 83. iBio Pharma Inc Major Business

Table 84. iBio Pharma Inc Covid-19 Treatment Product and Solutions

Table 85. iBio Pharma Inc Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Tonix Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 87. Tonix Pharmaceuticals Major Business

Table 88. Tonix Pharmaceuticals Covid-19 Treatment Product and Solutions

Table 89. Tonix Pharmaceuticals Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Curevac Corporate Information, Head Office, and Major Competitors

Table 91. Curevac Major Business

Table 92. Curevac Covid-19 Treatment Product and Solutions

Table 93. Curevac Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. ImmunoPrecise Corporate Information, Head Office, and Major Competitors

Table 95. ImmunoPrecise Major Business

Table 96. ImmunoPrecise Covid-19 Treatment Product and Solutions

Table 97. ImmunoPrecise Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. Global Covid-19 Treatment Revenue (USD Million) by Players (2019-2021)

Table 99. Global Covid-19 Treatment Revenue Share by Players (2019-2021)

Table 100. Breakdown of Covid-19 Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 101. Covid-19 Treatment Players Head Office, Products and Services Provided

Table 102. Covid-19 Treatment Mergers & Acquisitions in the Past Five Years

Table 103. Covid-19 Treatment New Entrants and Expansion Plans

Table 104. Global Covid-19 Treatment Revenue (USD Million) by Type (2016-2021)

Table 105. Global Covid-19 Treatment Revenue Share by Type (2016-2021)

Table 106. Global Covid-19 Treatment Revenue Forecast by Type (2021-2026)

Table 107. Global Covid-19 Treatment Revenue by Application (2016-2021)

Table 108. Global Covid-19 Treatment Revenue Forecast by Application (2021-2026)

Table 109. North America Covid-19 Treatment Revenue by Type (2016-2021) & (USD Million)

Table 110. North America Covid-19 Treatment Revenue by Type (2021-2026) & (USD Million)

Table 111. North America Covid-19 Treatment Revenue by Application (2016-2021) & (USD Million)

Table 112. North America Covid-19 Treatment Revenue by Application (2021-2026) & (USD Million)

Table 113. North America Covid-19 Treatment Revenue by Country (2016-2021) & (USD Million)

Table 114. North America Covid-19 Treatment Revenue by Country (2021-2026) & (USD Million)

Table 115. Europe Covid-19 Treatment Revenue by Type (2016-2021) & (USD Million)

Table 116. Europe Covid-19 Treatment Revenue by Type (2021-2026) & (USD Million)

Table 117. Europe Covid-19 Treatment Revenue by Application (2016-2021) & (USD Million)

Table 118. Europe Covid-19 Treatment Revenue by Application (2021-2026) & (USD Million)

Table 119. Europe Covid-19 Treatment Revenue by Country (2016-2021) & (USD Million)

Table 120. Europe Covid-19 Treatment Revenue by Country (2021-2026) & (USD Million)

Table 121. Asia-Pacific Covid-19 Treatment Revenue by Type (2016-2021) & (USD Million)

Table 122. Asia-Pacific Covid-19 Treatment Revenue by Type (2021-2026) & (USD Million)

Table 123. Asia-Pacific Covid-19 Treatment Revenue by Application (2016-2021) & (USD Million)

Table 124. Asia-Pacific Covid-19 Treatment Revenue by Application (2021-2026) & (USD Million)

Table 125. Asia-Pacific Covid-19 Treatment Revenue by Region (2016-2021) & (USD Million)

Table 126. Asia-Pacific Covid-19 Treatment Revenue by Region (2021-2026) & (USD Million)

Table 127. South America Covid-19 Treatment Revenue by Type (2016-2021) & (USD Million)

Table 128. South America Covid-19 Treatment Revenue by Type (2021-2026) & (USD Million)

Table 129. South America Covid-19 Treatment Revenue by Application (2016-2021) & (USD Million)

Table 130. South America Covid-19 Treatment Revenue by Application (2021-2026) & (USD Million)

Table 131. South America Covid-19 Treatment Revenue by Country (2016-2021) & (USD Million)

Table 132. South America Covid-19 Treatment Revenue by Country (2021-2026) & (USD Million)

Table 133. Middle East & Africa Covid-19 Treatment Revenue by Type (2016-2021) & (USD Million)

Table 134. Middle East & Africa Covid-19 Treatment Revenue by Type (2021-2026) & (USD Million)

Table 135. Middle East & Africa Covid-19 Treatment Revenue by Application (2016-2021) & (USD Million)

Table 136. Middle East & Africa Covid-19 Treatment Revenue by Application (2021-2026) & (USD Million)

Table 137. Middle East & Africa Covid-19 Treatment Revenue by Country (2016-2021) & (USD Million)

Table 138. Middle East & Africa Covid-19 Treatment Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Covid-19 Treatment Picture

Figure 2. Global Covid-19 Treatment Revenue Market Share by Type in 2020

Figure 3. Respiratory Support

Figure 4. Circulatory Support.

Figure 5. Convalescent Plasma Therapy

Figure 6. Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin)

Figure 7. Antimicrobial Therapy

Figure 8. Renal Failure and Renal Replacement Therapy

Figure 9. Lung Replacement Therapy

Figure 10. Immunotherapy

Figure 11. Other therapeutic measures

Figure 12. Covid-19 Treatment Revenue Market Share by Application in 2020

Figure 13. Children Picture

Figure 14. Adult Picture

Figure 15. Special Groups Picture

Figure 16. Global Covid-19 Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 17. Global Covid-19 Treatment Revenue and Forecast (2016-2026) & (USD Million)

Figure 18. Global Covid-19 Treatment Revenue Market Share by Region (2016-2026)

Figure 19. Global Covid-19 Treatment Revenue Market Share by Region in 2020

Figure 20. North America Covid-19 Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Europe Covid-19 Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Asia-Pacific Covid-19 Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. South America Covid-19 Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Middle East and Africa Covid-19 Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 25. Covid-19 Treatment Market Drivers

Figure 26. Covid-19 Treatment Market Restraints

Figure 27. Covid-19 Treatment Market Trends

Figure 28. Applied DNA Sciences, Inc Recent Developments and Future Plans

Figure 29. Codagenix Recent Developments and Future Plans

Figure 30. GeoVax Labs, Inc. Recent Developments and Future Plans

Figure 31. Takis Biotech Recent Developments and Future Plans

Figure 32. Evvivax Recent Developments and Future Plans

Figure 33. Zydus Cadila Recent Developments and Future Plans

Figure 34. MIGAL Galilee Research Institute Recent Developments and Future Plans

Figure 35. Generex Biotechnology Corporation Recent Developments and Future Plans

Figure 36. Moderna Therapeutics Recent Developments and Future Plans

Figure 37. Novavax Recent Developments and Future Plans

Figure 38. Bravovax Recent Developments and Future Plans

Figure 39. Ascletis Pharma Recent Developments and Future Plans

Figure 40. Janssen Pharmaceuticals Recent Developments and Future Plans

Figure 41. Altimmune Recent Developments and Future Plans

Figure 42. Greffex Inc. Recent Developments and Future Plans

Figure 43. CanSino Biologics, Inc. Recent Developments and Future Plans

Figure 44. ExpreS2ion Biotechnologies ApS Recent Developments and Future Plans

Figure 45. Clover Biopharmaceuticals Recent Developments and Future Plans

Figure 46. Vaxil Bio Ltd. Recent Developments and Future Plans

Figure 47. iBio Pharma Inc Recent Developments and Future Plans

Figure 48. Tonix Pharmaceuticals Recent Developments and Future Plans

Figure 49. Curevac Recent Developments and Future Plans

Figure 50. ImmunoPrecise Recent Developments and Future Plans

Figure 51. Global Covid-19 Treatment Revenue Share by Players in 2020

Figure 52. Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 53. Global Top 3 Players Covid-19 Treatment Revenue Market Share in 2020

Figure 54. Global Top 10 Players Covid-19 Treatment Revenue Market Share in 2020

Figure 55. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 56. Global Covid-19 Treatment Revenue Share by Type in 2020

Figure 57. Global Covid-19 Treatment Market Share Forecast by Type (2021-2026)

Figure 58. Global Covid-19 Treatment Revenue Share by Application in 2020

Figure 59. Global Covid-19 Treatment Market Share Forecast by Application (2021-2026)

Figure 60. North America Covid-19 Treatment Sales Market Share by Type (2016-2026)

Figure 61. North America Covid-19 Treatment Sales Market Share by Application (2016-2026)

Figure 62. North America Covid-19 Treatment Revenue Market Share by Country (2016-2026)

Figure 63. United States Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Canada Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Mexico Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Europe Covid-19 Treatment Sales Market Share by Type (2016-2026)

Figure 67. Europe Covid-19 Treatment Sales Market Share by Application (2016-2026)

Figure 68. Europe Covid-19 Treatment Revenue Market Share by Country (2016-2026)

Figure 69. Germany Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. France Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. United Kingdom Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Russia Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Italy Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Asia-Pacific Covid-19 Treatment Sales Market Share by Type (2016-2026)

Figure 75. Asia-Pacific Covid-19 Treatment Sales Market Share by Application (2016-2026)

Figure 76. Asia-Pacific Covid-19 Treatment Revenue Market Share by Region (2016-2026)

Figure 77. China Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Japan Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. South Korea Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. India Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Southeast Asia Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Australia Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. South America Covid-19 Treatment Sales Market Share by Type (2016-2026)

Figure 84. South America Covid-19 Treatment Sales Market Share by Application (2016-2026)

Figure 85. South America Covid-19 Treatment Revenue Market Share by Country (2016-2026)

Figure 86. Brazil Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Argentina Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Middle East and Africa Covid-19 Treatment Sales Market Share by Type (2016-2026)

Figure 89. Middle East and Africa Covid-19 Treatment Sales Market Share by Application (2016-2026)

Figure 90. Middle East and Africa Covid-19 Treatment Revenue Market Share by Country (2016-2026)

Figure 91. Turkey Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 92. Saudi Arabia Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 93. UAE Covid-19 Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 94. Methodology

Figure 95. Research Process and Data Source